Soluble interleukin-2 receptor and interleukin-6 levels: evaluation during cyclosporin A and methotrexate treatment in psoriatic arthritis (Q74545287)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9586691 AND SRC:MED&resulttype=core&format=json

11 November 2019

title

Soluble interleukin-2 receptor and interleukin-6 levels: evaluation during cyclosporin A and methotrexate treatment in psoriatic arthritis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9586691 AND SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

1 reference

1 reference

Antonio Sili Scavalli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9586691 AND SRC:MED&resulttype=core&format=json

11 November 2019

author name string

A Spadaro

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9586691 AND SRC:MED&resulttype=core&format=json

11 November 2019

E Taccari

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9586691 AND SRC:MED&resulttype=core&format=json

11 November 2019

F Sensi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9586691 AND SRC:MED&resulttype=core&format=json

11 November 2019

V Riccieri

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9586691 AND SRC:MED&resulttype=core&format=json

11 November 2019

A Zoppini

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9586691 AND SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 January 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9586691 AND SRC:MED&resulttype=core&format=json

11 November 2019

published in

Clinical Rheumatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9586691 AND SRC:MED&resulttype=core&format=json

11 November 2019

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9586691 AND SRC:MED&resulttype=core&format=json

11 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9586691 AND SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

83-85

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9586691 AND SRC:MED&resulttype=core&format=json

Low dose cyclosporine A in psoriatic arthritis: relation between soluble interleukin 2 receptors and response to therapy.

11 November 2019

cites work

1 reference

12 December 2020

Cytokine inter-relationships and their association with disease activity in arthritis

1 reference

12 December 2020

Interleukin-6 and soluble interleukin-2-receptor in psoriatic arthritis: correlations with clinical and laboratory parameters

1 reference

12 December 2020

Interleukin-2 receptor levels in the sera of rheumatoid arthritis patients treated with methotrexate

1 reference

12 December 2020

Comparison of cyclosporin A and methotrexate in the treatment of psoriatic arthritis: a one-year prospective study

1 reference

12 December 2020

Relationships between local inflammation, interleukin-6 concentration and the acute phase protein response in arthritis patients

1 reference

12 December 2020

Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy

1 reference

12 December 2020

Effect of cyclosporin A on interleukin-6 and soluble interleukin-2 receptor in patients with rheumatoid arthritis

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01450970

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9586691 AND SRC:MED&resulttype=core&format=json

11 November 2019

1 reference